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INTRODUCTION
Knee pain is one of the most common musculoskeletal complaints that bring people to their physician and the most common cause of knee pain is osteoarthritis. 1 Especially in females, knee osteoarthritis is the major cause of mobility impairment. 2, 3 Nearly, 45% of women over the age of 65 years have symptomatic findings of knee osteoarthritis while radiological evidence is found in 70% of those over 65 years. [2] [3] [4] In India, average menopausal age in women is 46.3 years as compared to 54 years in western countries. 5, 6 This predisposes Indian women at higher risk of developing osteoarthritis in earlier age as compared to their western counterparts. It could be due to loss of estrogen especially close to menopausal years at this time. 7, 8 Diabetes mellitus is a multi-system disease characterized by persistent hyperglycemia that has both acute and chronic biochemical and anatomical squeal which may cause irreversible damage to many organs and organ systems. 9 This disease affects connective tissues in many ways and causes different alterations in periarticular and musculoskeletal system. 10 Type 2-diabetes is frequently reported co-occurring disease in elderly patient with knee osteoarthritis. Singh et al reported that there was around 55% of knee osteoarthritis patients of over 65 years old having hypertension and 13% of them showing Type 2 Diabetes Mellitus. 11 Many studies have reported a correlation of osteoarthritis with duration of diabetes mellitus and poor glycaemic control. [12] [13] [14] [15] [16] However, the link between diabetes mellitus and osteoarthritis is not well defined, but it may be due to deleterious role of excess of glucose through the accumulation of advanced glycation end products, oxidative stress and promotion of systemic inflammation. [16] [17] [18] [19] So, there is a need of biomarker that identifies type 2 diabetic individuals who are at higher risk of developing osteoarthritis.
Vascular cell adhesion molecule-1 emerged as a strong and independent predictor for severe osteoarthritis. 20 Previous studies have reported that hyperglycemia, hyperinsulinemia or insulin resistance are responsible for elevation of this adhesion molecule. 21, 22 VCAM-1 is an inducible cell surface sialo glycoprotein expressed on chondrocytes and synovial fibroblasts. VCAM-1 mediates the adhesion of lymphocytes, monocytes, eosinophils, and basophils to vascular endothelium and plays a role in the development of inflammation. 23 VCAM-1 mediates the interaction of chondrocytes with immune cells and could thus by itself contribute to immune-mediated cartilage damage. 24 Therefore, the present study is aimed to assess the serum level of sVCAM-1 in type 2-diabetic postmenopausal women having early stage of knee osteoarthritis.
METHODS
The present study has been carried out in the Department of Biochemistry and Department of Orthopaedics, G.R Medical College and J.A. Group of Hospitals, Gwalior. Total 200 human subjects were taken in the study. Out of which 100 type 2-diabetic postmenopausal women of age 50 years or above having clinical symptoms of knee osteoarthritis were considered as cases and 100 normal healthy individuals of same age as control.
Inclusion criteria
Postmenopausal women suffering from type 2 diabetes mellitus with complain of knee pain lasting longer than 1 month in addition to at least 3 of the following 6 criteria according to ACR guideline: age>50 years, morning stiffness more than 30 minutes, crepitus, bony enlargement, bony tenderness and absence of palpable warmth.
Exclusion criteria
Patients taking any hormone replacement therapy (HRT), non-steroidal anti-inflammatory drugs (NSAIDs), having metabolic bone disease, rheumatoid arthritis, serious systemic diseases, history of knee trauma or knee injury, cardiac heart diseases. Before starting analysis, the written consent was taken from all subjects. The study has been approved by institutional ethical committee and was carried out by keeping all norms in mind. The clinical manifestations of disease, personal history of patients was recorded in study proforma.
8ml of fasting blood sample was taken from all subjects under all aseptic precautions and dispensed into three tubes i.e. fluoride, EDTA and plain tubes. Serum and plasma from plain and fluoride tubes were separated after centrifugation for 5-10 minutes at 3000 rpm and analysed for routine biochemical parameters and serum was stored at -20̊ C in aliquots for ELISA analysis of sVCAM-1. Levels of Fasting blood sugar, total cholesterol, triglycerides, HDL-C were measured by standard biochemical kits (Erba) using BS 400 fully automated analyser (Mindray). EDTA tube was used for estimation of HbA1c (estimated by turbidimetric immunoassay). LDL and VLDL were calculated by using Friedewald formula. Serum levels of sVCAM-1was measured by enzyme-linked immunosorbent assay kit (Diaclone Elisa Kit).
Statistical analysis
The results were expressed as Mean ± Standard Deviation. The statistical differences between cases and control were determined by student independent t-test. Data analyses were performed with the Statistical Package for the Social Sciences, version 21.0 (SPSS, Chicago, Illinois, USA). In order to determine correlation, statistical analysis was carried out by using spearman's rank correlation coefficient. The p value less than 0.05 were considered as significant.
RESULTS
The descriptive statistics of glycemic status, lipid profile and sVCAM-1 are shown in (Table 1 ). The mean value of FBS, HbA1c and lipid profile such as TG, TC, LDL-C and VLDL-C were highly significantly increased while HDL-C was significantly decreased (p<0.001) in cases as compared to control. The serum level of sVCAM-1 was highly found statistically highly significantly increased (p<0.001) in Type 2-diabetic subject suffering from knee osteoarthritis as compared to control. Correlation analysis among the investigated serum parameters revealed a significant positive correlation of VCAM-1 with FBS, HbA1c, Total Cholesterol, and a significant negative correlation of VCAM-1 with HDL-C (Table 2 ). 
DISCUSSION
Knee osteoarthritis is a major public health problem especially in postmenopausal women. Type 2 diabetic postmenopausal women are at higher risk of incidence, severity and earlier onset of knee osteoarthritis than nondiabetic postmenopausal women. In diabetes hyperglycemia plays a role for joint degradation and may be induces osteoarthritis. 25 In this study, we found highly significant increased levels of HbA1c and FBS (p˂0.001) in diabetic postmenopausal women with knee osteoarthritis compared to controls. Which is same as Cimmino et al who reported that mean fasting plasma glucose was significantly higher in women with osteoarthritis as compared to controls and out of which 5.5 percent women had type 2 diabetes. 26 Rouen et al reported that in postmenopausal women having type 2 diabetes glucose control is associated with the severity of those symptoms commonly attributed to menopause such as joint pain. 27 Hart et al also reported that in women of age 45-64 years blood glucose was associated with unilateral and bilateral knee osteoarthritis. 28 The possible explanation of link between hyperglycemia and osteoarthritis that hyperglycemia can induce an inflammatory state, and that an inflammatory state might predispose cartilage to damage that leads to osteoarthritis. [25] The level of TG, TC, LDL-C, VLDL-C were also found significantly increased while HDL-C was found significantly decreased in diabetic postmenopausal women with knee osteoarthritis as compared to controls. The alteration of lipid profile i.e. dyslipidemia, observed in our study may be due to deposition of lipids, particularly in chondrocytes, which aggravates lipid metabolism disorders in degenerative articular cells and promotes the development of osteoarthritis which is consistent with the study of Hart et al. 28 Some epidemiological studies have also shown that raised serum cholesterol and reduced HDL level to be risk factor for osteoarthritis development and progression. 29, 30 Along with raised FBS and dyslipidemia, in this study the serum level of sVCAM-1 was found statistically highly significantly increased (p<0.001) in diabetic postmenopausal having clinical symptoms of knee osteoarthritis as compared to controls. Hoeven et al also reported the increased level of VCAM-1 in elderly women having knee osteoarthritis than those without knee osteoarthritis. The increased levels of sVCAM-1 in our study shows inflammation or active cartilage damage. In this study, a positive correlation of hyperglycemia with VCAM-1 is present which is consistent with the hypothesis that high intracellular glucose concentration in diabetes promotes the formation of advanced glycation end products. AGE compounds interact with membrane receptors called RAGE present on chondrocytes and give rise to a cascade of events that promote release of proinflammatory factors such as TNF-α, and activate transcription factors such as Nf-kB, which in turn induces VCAM-1 and promotes inflammation and cartilage degradation. 25, 32, 33 Therefore, in our study hyperglycemia, dyslipidemia with VCAM-1 increase is suggestive of onset of inflammation or cartilage damage in knees.
CONCLUSION
This study concluded that hyperglycemia, dyslipidemia with VCAM-1 increase in diabetic postmenopausal women is suggestive of onset of osteoarthritis. 
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Introduction
Osteoarthritis is the most common joint disorder and one of the leading causes of pain, functional disability and reduced health-related quality of life. It is characterized by slow progressive degeneration of articular cartilage, subchondral bone sclerosis, synovial inflammation and marked osteophyte formation, with the involvement of whole joint. [1] Epidemiological observations showed that after the age of 50, osteoarthritis, 
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particularly of the knee, is more common in women than in men and suggesting that estrogen deficiency may play an important role in the onset or progression of osteoarthritis. [2] [3] [4] Clinically, this condition is characterized by joint pain, tenderness, limitation of movement, crepitus, occasional effusion, and variable degrees of local inflammation. For a long time osteoarthritis was considered as non-inflammatory condition, but now it become evident that low grade of inflammation mainly associated with synovitis has been reported in osteoarthritis. [5] [6] [7] [8] Synovitis is commonly seen in early and advanced phase of osteoarthritis and has been associated with knee pain and cartilage degeneration. [9] [10] [11] [12] ] C-reactive protein (CRP) serving as a marker for systemic inflammation, several studies showing a relationship between serum CRP levels and osteoarthritis of the knee. [13] [14] [15] Although, CRP is not taken as an optimal marker for inflammation in osteoarthritis; other putative markers have been associated with some osteoarthritis phenotypes. These include proinflammatory cytokines, cell adhesion molecules and adiponectin. The inflammatory changes occur in the synovium include synovial hypertrophy and hyperplasia with infiltration of the underlying tissue by various inflammatory cells. [16] [17] [18] [19] Adhesion molecules play an important role during inflammatory process because they enable inflammatory cells to migrate to inflamed compartment. Vascular cell adhesion molecule-1 is an inducible cell surface sialoglycoprotein expressed on chondrocytes and synovial fibroblasts. VCAM-1 mediates the adhesion of lymphocytes, monocytes, eosinophils, and basophils to vascular endothelium and plays a role in the development of inflammation. [20] Therefore, the aim of this study is to assess the role of soluble VCAM-1 in postmenopausal women to detect early stage of knee osteoarthritis.
Materials and Methods
The present study has been carried out in the Department of Biochemistry and Department of Orthopaedics, G.R Medical College & J.A. Group of Hospitals, Gwalior. Total 200 human subjects were taken in the study. Out of which 100 postmenopausal women with symptoms of knee osteoarthritis were taken as cases and 100 normal healthy individuals of same age as control. Inclusion criteria: Postmenopausal women having no menstruation for more than 12 months with complain of knee pain lasting longer than 1 month in addition to atleast 3 of the following 6 criteria according to American College of Rheumatology Criteria for knee osteoarthritis: age>50 years, morning stiffness more than 30 minutes, crepitus, bony enlargement, bony tenderness and absence of palpable warmth. Exclusion criteria: Patients taking any hormone replacement therapy (HRT), non steroidal anti inflammatory drugs (NSAID), having any metabolic bone disease, rheumatoid arthritis, serious systemic diseases, history of knee trauma or knee injury, cardiac heart diseases, diabetes. Before starting analysis, the written consent was taken from all subjects. The study has been approved by institutional ethical committee and was carried out by keeping all norms in mind. The clinical manifestations of disease, personal history of patients were recorded in study proforma. 7 ml of blood sample was taken from all subjects under all aseptic precautions. Blood sample was collected in plain vial and incubated at 37˚C for 30 minutes. After incubation, clot was removed and remaining sample was taken in centrifuge test tube. Samples were centrifuged at 3000rpm for 10 to 20 minutes. Supernatant was collected in clean and dry serum test tube and stored at -2 C for further estimation of C-reactive protein, estrogen hormone and soluble vascular cell adhesion molecule-1(sVCAM-1). CRP was assayed in serum by latex-enhanced turbidimetric immunoassay. The serum level of soluble VCAM-1 level and estrogen hormone were estimated by ELISA technique. The results were expressed as Mean ± Standard Deviation .The statistical differences between cases and control were determined by student independent t-test. Correlation was determined by using spearman's JMSCR Vol||05||Issue||08||Page 26745-26750||August 2017 rank correlation coefficient. Data analyses were performed with the Statistical Package for the Social Sciences, version 21.0 (SPSS, Chicago, Illinois, USA). The p value less than 0.05 were considered as significant.
Results
Table No 1:
showing the status of CRP, estrogen hormone and soluble VCAM-1 level in control and postmenopausal women with symptoms of knee osteoarthritis (cases). The mean level of CRP was found significantly increased (p<0.01) while the serum levels of soluble VCAM-1 was found statistically highly significantly increased (p<0.001) and estrogen hormone was found highly significantly decreased (p<0.001) in postmenopausal women with symptoms of knee osteoarthritis as compared to control. Table No 2: showing the inverse correlation between soluble VCAM-1 and estrogen hormone while positive correlation between soluble VCAM-1 and CRP in postmenopausal women with symptoms of knee osteoarthritis. Results are presented in r value * Significant at p<0.01
Discussion
Osteoarthritis is now considered as a whole joint disease in which bone, synovia and other joint structures are affected and adhesion molecules in the circulation contribute to the pathogenesis of osteoarthritis through cell-cell or cell-matrix interactions. In our study, the mean level of serum soluble VCAM-1 was found statistically highly significant (p<0.001) in postmenopausal women with symptoms of knee osteoarthritis as compared to control (Table No 1 ). This is consistent with the study of Hoeven et al who reported the increased level of VCAM-1 in elderly women having knee osteoarthritis than those without knee osteoarthritis. [21] Other studies also reported the elevated level of soluble VCAM-1 in serum of patients with osteoarthritis. [22] [23] [24] In joints, VCAM-1 is expressed by microvascular endothelial cells, synovial fibroblasts, and chondrocytes. [25] It is not appreciably expressed on resting vascular endothelium but is rapidly induced in response to a number of inflammatory stimuli, such as TNF-a, IL-1β. [26] During cartilage damage, chondrocytes can produce or respond to a large number of cytokines such as tumor necrosis factor-α and interleukin-1β. [27] These proinflammatory cytokine activation alters the phenotype of quiescent endothelial cells, which in turn increases the synthesis of VCAM-1. [28] The increased level of soluble VCAM-1 in our study shows active cartilage damage or an inflammatory component in osteoarthritis. The cartilage is the prime site of osteoarthritis disease and is very sensitive to change in sex hormone level. Our study showed significant decreased levels of estrogen hormone (p<0.001) in postmenopausal female subjects with symptoms of knee osteoarthritis as compared to control postmenopausal women. This is in agreement with the studies of Sheikh et al [29] . The correlative study between VCAM-1 and estrogen hormone showed an inverse relationship between them. It may be due to depletion of estrogen hormone during menopause, which induces VCAM-1 production. The mechanism through which estrogen decreases cytokine induced
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Estrogen -0.281* JMSCR Vol||05||Issue||08||Page 26745-26750||August 2017 VCAM-1 production by inhibition of NF-κβ, AP-1 and GATA transcription factors. [30] In this study the serum level of CRP was also found significantly high in postmenopausal women with symptoms of knee osteoarthritis as compared to control which is in consistent with the study of Spector et al who reported modestly but significant increase of CRP level in women with early stage of knee osteoarthritis [14] . CRP is an acute phase protein, which reflects a measure of the acute-phase response. Elevated level of CRP in serum may reflect subclinical inflammation in affected joints, mediated by cytokines. Furthermore we also found a positive correlation between CRP and VCAM-1 in this study. Thus, these findings support that inflammation is a component of the early events leading to clinical osteoarthritis.
Conclusion
It is therefore concluded from the study that in postmenopausal women lack of estrogen hormone induces soluble VCAM-1 production. VCAM-1 mediates the interaction of chondrocytes with immune cells and could thus by itself contribute to immune-mediated cartilage damage. Hence, serum level of soluble VCAM-1 could be used as an early biomarker for inflammatory response and cartilage damage in osteoarthritis. If in postmenopausal women the periodic check up for estrogen and VCAM-1 is carried out the occurrence and severity of osteoarthritis could be prevented.
